For The Better

Medtronic may be among the companies to dominate the AI healthcare market.

Medtronic may be among the companies to dominate the AI healthcare market.

Investors appear to be anticipating an underwhelming first-quarter report from the bioprocessing company.

Investors appear to be anticipating an underwhelming first-quarter report from the bioprocessing company.

The Fed expects a “mild” downturn.

The Fed expects a “mild” downturn.

Investors love that Spotify is a growth stock — with all that implies about its valuation.

Investors love that Spotify is a growth stock — with all that implies about its valuation.

Investors worry that an economic recession could hit entire swaths of the stock market hard.

Investors worry that an economic recession could hit entire swaths of the stock market hard.

After a strong start to 2023, the virology-focused biopharma company has hit a regulatory speed bump.

After a strong start to 2023, the virology-focused biopharma company has hit a regulatory speed bump.

GAAP earnings at GE HealthCare were less than half the headline number.

GAAP earnings at GE HealthCare were less than half the headline number.

The stock isn’t as expensive as it may look at first glance.

The stock isn’t as expensive as it may look at first glance.

A big new product is doing better than expected.

A big new product is doing better than expected.

The clinical-stage biotech announced promising news regarding a potential therapy for inflammatory pulmonary diseases.